Default Image
4, Jun 2026
Multiangle Simulations Uncover How Neutrinos Can Help or Hinder Supernova Explosions

Core-collapse supernovae are thought to be powered by neutrino-driven energy transport. Now, researchers in Japan have shown that neutrino fast flavor conversion can either enhance or suppress supernova explosions depending on the progenitor star. Using advanced multiangle neutrino radiation hydrodynamics simulations, the team demonstrated that the mass accretion rate is…

Default Image
4, Jun 2026
Rare Laparoscopic Whipple Procedure Successfully Performed on Patient with Previous Open Pancreatic Surgery at KIMS Hospitals

Hyderabad, June 04: Doctors at KIMS Hospitals, Kondapur, successfully performed a rare and highly complex laparoscopic Whipple procedure on a 52-year-old woman who had previously undergone open pancreatic surgery for chronic calcific pancreatitis, offering her a new lease of life. Sharing details of the case, Dr. Ch. Naveen Kumar, Consultant Surgical Gastroenterologist, said that the patient, a resident of Hyderabad, had undergone a lateral pancreaticojejunostomy…

Default Image
4, Jun 2026
RWJBarnabas Health Expands Lifesaving Naloxone Initiative Across New Jersey

West Orange, NJ June 4: RWJBarnabas Health, through its Institute for Prevention and Recovery (IFPR), is expanding its hospital-based naloxone distribution initiative to individuals and communities across the state, increasing access to life-saving resources and connecting individuals to recovery support services. The program aims to distribute more than 15,000 naloxone…

Default Image
4, Jun 2026
FSU Chemist Points to Academic Research Behind Promising Pancreatic Cancer Treatment

By Stephen Stone, National Media Strategist A promising new pancreatic cancer drug that nearly doubled survival times in a recent clinical trial is drawing attention not only for its potential impact on patients, but also for the university research that helped make it possible. In recent clinical trials by oncology…

Default Image
3, Jun 2026
New Pancreatic Cancer Drug Nearly Doubles Survival in Landmark Trial

A major breakthrough in pancreatic cancer treatment unveiled at the American Society of Clinical Oncology (ASCO) annual meeting could mark a turning point for one of the deadliest and most difficult-to-treat cancers. Researchers reported that an experimental targeted therapy, daraxonrasib, nearly doubled median survival for patients with previously treated metastatic…

Default Image
3, Jun 2026
Learn CPR, save a life: Lodge Keys and GVK Green Health Services offer hands-on training on June 6

 Watchmen, domestic servants, street vendors, auto/cab drivers, security guards, and students are especially invited Hyderabad, June 3: Lodge Keys No. 297, the city’s primary unit of Freemasonry, will organise a CPR Training Programme on June 6, 2026, from 2:00 PM to 5:30 PM at the Goshamahal Baradari Masonic Building, Goshamahal,…

Default Image
2, Jun 2026
Body Mass Index Found to Drastically Underestimate Obesity Levels in the United States

LOS ANGELES: Could the way doctors traditionally measure obesity allow a subset of people with obesity-related health risks slip through the cracks? Medical experts have typically calculated obesity using body mass index (BMI), a calculation based on a person’s height and weight. In the last year and a half, however,…

Default Image
1, Jun 2026
Fleetguard Filters Supports ‘Still, I Rise’ CSR Initiative for Multiple Sclerosis Awareness on World MS Day

Pune, June 1: Fleetguard Filters Pvt. Ltd.  supported a short film, ‘Still, I Rise’ aimed at raising awareness about Multiple Sclerosis (MS). The film was screened at the National Film Archive of India Pune, on May 30, 2026. Directed by Rahul Panshikar the short film highlights the strength, courage, and…

Default Image
1, Jun 2026
Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Reduces Risk of Metastasis and Death

BOSTON, Jun 1: High-risk localized and locally advanced prostate cancer patients treated with apalutamide — a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) — plus hormone therapy before and after prostate cancer surgery resulted in more major pathologic responses and reduced the risk of metastasis or death, meeting both primary…

Default Image
1, Jun 2026
Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival

Los Angeles  June 01: A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in The New England Journal of Medicine. Andrew Hendifar, MD, professor…